Researchers at The University of Texas at Austin have identified a network of genes that appear to work together in determining alcohol dependence. The findings, which could lead to future treatments and therapies for alcoholics and possibly help doctors screen for alcoholism, are being published in the journal Molecular Psychiatry.
By comparing patterns of genetic code from the brain tissue of alcoholics and nonalcoholics, the researchers discovered a particular set of genes co-expressed together in the individuals who had consumed the most alcohol. Specifically, certain sets of genes were strongly linked as networks in alcoholics, but not in nonalcoholics.
This provides the most comprehensive picture to date of the gene sets that drive alcohol dependence. The medical community now has a much clearer picture of where specific traits related to alcohol dependence overlap with specific expressions in genetic code.
Scientists have known for some time that genetics play a role in alcoholism and addiction and that the tendency for dependence to be genetically linked is more complicated than the presence or absence of any one gene. The new research, however, represents the first time scientists used revolutionary bioinformatics technology of RNA sequencing to identify the specific group of different genes that, expressed together, are highly correlated with alcohol dependence.
The team hopes their model can serve as a type of Wikipedia of alcohol dependence, helping to break down the complexities of alcohol dependence and becoming a reference for future research into drug therapies.
Only three drugs have approval from the Food and Drug Administration to treat alcoholism, and none offers a silver bullet in helping people dependent on alcohol end their addiction. The identification of genetic factors and networks in the brains of alcoholics gives drug researchers more information to work from and may one day allow for better screenings to evaluate a person’s risk factors for alcohol dependence, possibly even before the onset of heavy drinking.
Source: University of Texas at Austin
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.